Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies.
Shi W, Wang Y, Zhao Y, Kim JJ, Li H, Meng C, Chen F, Zhang J, Mak DH, Van V, Leo J, St Croix B, Aparicio A, Zhao D.
Shi W, et al. Among authors: leo j.
Sci Transl Med. 2023 May 10;15(695):eadf6724. doi: 10.1126/scitranslmed.adf6724. Epub 2023 May 10.
Sci Transl Med. 2023.
PMID: 37163614
Free PMC article.